Equities

Dr Reddy's Laboratories Ltd

Dr Reddy's Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)13.99
  • Today's Change-0.31 / -2.17%
  • Shares traded1.45m
  • 1 Year change+2.46%
  • Beta0.5439
Data delayed at least 15 minutes, as of Nov 21 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, Dr Reddy's Laboratories Ltd (RDY:NYQ) closed at 13.99, 8.45% above its 52-week low of 12.90, set on Dec 11, 2023.
52-week range
Today
12.90Dec 11 202316.89Aug 09 2024
Open14.05
High14.25
Low13.93
Bid13.71
Offer14.08
Previous close14.30
Average volume927.63k
Shares outstanding833.05m
Free float--
P/E (TTM)18.86
Market cap11.98bn USD
EPS (TTM)0.7583
USD
Annual div (ADY)0.0952
USD
Annual div yield (ADY)0.67%
Div ex-dateJul 30 2024
Div pay-dateAug 12 2024
Data delayed at least 15 minutes, as of Nov 21 2024 21:10 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.